Abstract
Objective:
The objective of this work was to generate information about the profile of the patients submitted to Intravitreal Injections (IVIs) and also to evaluate the indications and costs of the procedure.
Methods:
The study was carried out with own protocols, applied through the analysis of medical records of patients submitted to IVIs at the State Public Servant Hospital of São Paulo from January 2017 to June 2018. Data were analyzed in the form of descriptive study.
Results:
The results showed that 3181 injections were performed in 1421 eyes in the study period; the main drug injected was Bevacizumab; the main pathology treated was Diabetic Maculopathy; and the cost with these procedures was at least R$ 776,257.56. Most diabetic patients did not have adequate glycemic control. Many patients with AMD had no documented improvement in Visual Acuity.
Conclusion:
It was concluded that deep analyzes about the indications of IVIs should be performed for the benefit of public servants of São Paulo. The information generated by this study can be used to improve the service through the development of therapeutic protocols, as well as serving as a starting point for new research and actions related to the topic.
Keywords:
Retina; Intravitreal injection; Anti-VEGF